Design, synthesis, and biological evaluation of phenylamino-substituted 6,11-dihydro-dibenzo[b,e]oxepin-11-ones and dibenzo[a,d]cycloheptan-5-ones:: Novel p38 MAP kinase inhibitors

被引：40

作者：

Laufer, Stefan A. ^{[1
]}

Ahrens, Gabriele M. ^{[1
]}

Karcher, Solveigh C. ^{[1
]}

Hering, Joerg S. ^{[1
]}

Niess, Raimund ^{[1
]}

机构：

[1] Univ Tubingen, Dept Pharmaceut & Med Chem, Inst Pharm, D-72076 Tubingen, Germany

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 26期

关键词：

D O I：

10.1021/jm061072p

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The pathogenesis of chronic inflammatory diseases is promoted by various pro-inflammatory cytokines. p38 MAP kinase seems to be a valid target as it controls proinflammatory cytokine levels on both transcriptional and translational levels. Starting from benzophenone-type inhibitors, a rigidisation strategy lead to 3-amino-6,11-dihydro-dibenzo[b,e]thiepin-11-one, phenylamino-substituted 6,11-dihydro-dibenzo[b,e]oxepin-11-ones, and dibenzo[a,d]cyclohepten-5-ones. Synthesis, p38 inhibition, and CYP-inhibition of selected compounds are described.

引用

页码：7912 / 7915

页数：4

共 15 条

[1] Adams JL, 2001, PROGR MED CHEM, V38, P1, DOI 10.1016/S0079-6468(08)70091-2
[2] Cirillo Pier F., 2002, Current Topics in Medicinal Chemistry, V2, P1021, DOI 10.2174/1568026023393390
[3] EICHER T, 1988, SYNTHESIS-STUTTGART, P525
[4] Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket
Gum, RJ
McLaughlin, MM
Kumar, S
Wang, ZL
Bower, MJ
Lee, JC
Adams, JL
Livi, GP
Goldsmith, EJ
Young, PR
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) : 15605 - 15610
[5] TRICYCLIC ARYL-SUBSTITUTED ANTICOCCIDIAL AZAURACILS
KLUGE, AF
CAROON, JM
UNGER, SH
RYLEY, JF
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (06) : 529 - 536
[6] Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase
Kumar, S
Jiang, MS
Adams, JL
Lee, JC
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (03) : 825 - 831
[7] p38 map kinases: Key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S
Boehm, J
Lee, JC
[J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (09) : 717 - 726
[8] An immunosorbent, nonradioactive p38 MAP kinase assay comparable to standard radioactive liquid-phase assays
Laufer, S
Thuma, S
Peifer, C
Greim, C
Herweh, Y
Albrecht, A
Dehner, F
[J]. ANALYTICAL BIOCHEMISTRY, 2005, 344 (01) : 135 - 137
[9] Synthesis and structure-activity relationship of aminobenzophenones.: A novel class of p38 MAP kinase inhibitors with high antiinflammatory activity
Ottosen, ER
Sorensen, MD
Björkling, F
Skak-Nielsen, T
Fjording, MS
Aaes, H
Binderup, L
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (26) : 5651 - 5662
[10] Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Pargellis, C
Tong, L
Churchill, L
Cirillo, PF
Gilmore, T
Graham, AG
Grob, PM
Hickey, ER
Moss, N
Pav, S
Regan, J
[J]. NATURE STRUCTURAL BIOLOGY, 2002, 9 (04) : 268 - 272

← 1 2 →